Skip to main content
. 2010 Dec 31;40(12):625–631. doi: 10.4070/kcj.2010.40.12.625

Table 4.

Changes in the levels of inflammatory, insulin resistance markers and lipid profile during the follow-up period

graphic file with name kcj-40-625-i004.jpg

*p<0.05 vs. baseline, p<0.05 vs. placebo. hs-CRP: high-sensitivity C-reactive protein, HDL-C: high density lipoprotein-cholesterol, IL-6: interleukin-6, LDL-C: low density lipoprotein-cholesterol, TNF-α: tumor necrosis factor-alpha